about
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitorAminopeptidase A is a functional target in angiogenic blood vesselsGermline mutation of INI1/SMARCB1 in familial schwannomatosisMultiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumorsOligodendroglioma: pathology, molecular mechanisms and markersIn vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine gliomaEffects of dual targeting of tumor cells and stroma in human glioblastoma xenografts with a tyrosine kinase inhibitor against c-MET and VEGFR2Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status.Hypoxia in a human intracerebral glioma model.A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.Human pontine glioma cells can induce murine tumors.The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.Subventricular spread of diffuse intrinsic pontine glioma.Implementation of a multi-institutional diffuse intrinsic pontine glioma autopsy protocol and characterization of a primary cell culture.The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.Quantitative short echo time 1H MRSI of the peripheral edematous region of human brain tumors in the differentiation between glioblastoma, metastasis, and meningioma.Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Sträussler-Scheinker disease phenotype: comparison with similar cases from the literature.New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORUpregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases.DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.Primary intracranial germ-cell tumors in adults: a practical review.Comparative genomic hybridization: practical guidelines.Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.Massive reduction of tumour load and normalisation of hyperprolactinaemia after high dose cabergoline in metastasised prolactinoma causing thoracic syringomyeliaIntramedullary enterogenous cyst presenting with spastic paraparesis during two consecutive pregnancies: a case report.Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular proteinEvolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.Molecular pathogenesis of oligodendroglial tumors.RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.Choroid plexus carcinoma: a report of two cases and review of the literature.Diffuse glioma growth: a guerilla warMultivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targetingIncreased mitochondrial activity in a novel IDH1-R132H mutant human oligodendroglioma xenograft model: in situ detection of 2-HG and α-KG.
P50
Q21195751-069FF890-58C8-4436-883F-016BC4299620Q24313578-3500318C-AF5E-4B66-8849-F223EB8DD2FEQ24682982-F6D7CC96-AC2C-4F2D-9C66-30ACB44CA6C4Q24685905-8511D727-9395-4572-B5FE-0474BCACD329Q27002448-274DFDAB-3153-4054-A101-82CAEEAD9E16Q28487205-D42938E0-25EE-410D-8386-F4847CED4CD7Q28487568-E9B896CD-645B-4416-8541-7FFE69C8DF67Q33179393-72581442-0AF9-4710-902F-A33065D1AC13Q33181001-B356E1BE-1A5F-4061-8133-459F6F678EADQ34018659-DDA45F72-8681-408C-B832-BF4D7CFD1B9CQ34054150-1F39CA83-B002-4165-B3A3-58F9EE63B0ADQ34061985-CAF78F8D-D99A-4D67-B6C3-57C85F4FCDD3Q34167497-3538EA95-E974-45BC-B775-58D362BA3984Q34291274-19B1FA47-D14A-419C-A978-629FFCC018C5Q34315871-4521B507-BDCA-4E41-970D-B8CC15D33FB1Q34320779-7AA1233C-DEC0-47B6-A8AC-841E45DB23B1Q34332857-7A8D9BE0-A56A-4057-8B93-27453F3D046BQ34416029-52154169-804E-48C3-B0C8-AF84080D743CQ34463067-99E475F5-3265-466C-8EED-C5715E5B3B81Q34515911-9CD5B03F-4120-42D3-8532-5F16907AE730Q34523475-EE3EFB8C-5635-4CB4-987F-9444D13ECEFFQ34584209-6BE0DE77-2BC1-40DC-8FC0-CCCD226C7899Q34590458-378FA137-5D24-4EE4-8B46-50C35A3B0B0AQ34633797-9C161B3F-6D19-4CB8-B47B-C88C261BEDDEQ35013147-C72DC3E3-68F7-4A2D-86B8-19C9C4A84579Q35183966-0A372433-1359-4455-8175-71C80A2E65C4Q35204658-100296D5-5D96-42C1-8660-B6A8208EF327Q35477380-3235BF1D-EBEE-4DD3-AD90-6B2AC9919DF3Q35572528-68CC8528-B24F-4341-83D9-19BBC5A314FFQ35747784-C31E2A2D-B0C4-48C7-8CAF-CADE9E4F42C1Q35787908-A1F57C05-072F-4A59-877B-AE27C1409B4AQ35787956-BCA38571-1588-4E95-AB87-D8053574FBE0Q36021563-BEB6A7AA-1277-424A-8E51-D40BEC01E06FQ36278318-04F3A846-C651-4090-BBCD-BF6F72CCE76BQ36466870-8469363D-3E82-422D-94AB-2BC88C525BB7Q36618241-9D9B1784-231F-42E1-8C28-DA1E6F56A0D9Q36823249-812EF530-64C8-4119-B2DF-C0C5DB496731Q36931690-02E08736-8C16-4535-9E8C-CE653838FA4AQ37312731-4CE4858D-CC78-4C76-8722-43C8636D354CQ37485784-28333279-E04C-4C80-8C5C-D3B92145E379
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
P. Wesseling
@nl
P. Wesseling
@sl
Pieter Wesseling
@en
Pieter Wesseling
@es
type
label
P. Wesseling
@nl
P. Wesseling
@sl
Pieter Wesseling
@en
Pieter Wesseling
@es
altLabel
P. Wesseling
@en
Wesseling P
@en
prefLabel
P. Wesseling
@nl
P. Wesseling
@sl
Pieter Wesseling
@en
Pieter Wesseling
@es
P1053
H-8114-2014
P106
P21
P31
P3829
P496
0000-0001-5453-5201